New antibody treatment trial offers hope for lupus patients
NCT ID NCT07185269
Summary
This study is testing an experimental antibody called SSGJ-626 for people with systemic lupus erythematosus (SLE), a chronic autoimmune disease. Researchers will compare SSGJ-626 plus standard care against placebo plus standard care in 198 adults with active lupus symptoms. The goal is to see if this new treatment is safe and helps control lupus disease activity better than current treatments alone.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Peking Union Medical College Hospital
RECRUITINGBeijing, Beijing Municipality, 100730, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.